The Anticancer Peptide CIGB-552 Exerts Anti-Inflammatory and Anti-Angiogenic Effects through COMMD1

CIGB-552 is a synthetic anti-tumor peptide capable of reducing tumor size and increasing the lifespan of tumor-bearing mice. Part of its anti-cancer effects consists of inducing apoptosis, modulating NF-kB signaling pathway, and the angiogenesis process. Although one of its major mediators, the COMM...

Descripción completa

Detalles Bibliográficos
Autores principales: Daghero, Hellen, Fernández Massó, Julio Raúl, Astrada, Soledad, Guerra Vallespí, Maribel, Bollati-Fogolín, Mariela
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7795859/
https://www.ncbi.nlm.nih.gov/pubmed/33396282
http://dx.doi.org/10.3390/molecules26010152

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7795859/
https://www.ncbi.nlm.nih.gov/pubmed/33396282
http://dx.doi.org/10.3390/molecules26010152

Ejemplares similares